NCT03374124

Brief Summary

Previous studies have demonstrated that the eosinophilic inflammation of nasal mucosa is associated with the uncontrolled condition of chronic rhinosinusitis after surgery. However, the definition of the eosinophilic chronic rhinosinusitis is not very clear. Japanese researchers have designed a scoring system to diagnose eosinophilic chronic rhinosinusitis. In this study, the investigators hope to examine the practicability of this scoring system and have a better knowledge of eosinophilic chronic rhinosinusitis in china.The retrospective study was conducted in a tertiary hospital. Participants received functional endoscopic sinus surgery more than 1 years were called back for evaluation. A diagnosis cut off value of eosinophil count was determined by the surgery prognosis. Then different factors were compared between participants with eosinophilic CRS and those with non-eosinophilic CRS to establish the appropriated diagnosis approach for eosinophilic CRS.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

November 27, 2017

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 15, 2017

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

December 15, 2017

Status Verified

December 1, 2017

Enrollment Period

2 years

First QC Date

November 27, 2017

Last Update Submit

December 11, 2017

Conditions

Keywords

Chronic rhinosinusitisEosinophilSurgeryDiagnosis

Outcome Measures

Primary Outcomes (2)

  • nasal symptoms

    presence of bothersome congestion or rhinorrhea or olfactory loss or headache.(VAS more than 7 points).

    through study completion, an average of 2 year

  • endoscopic appearance indicate the uncontrol of CRS

    The presence of diseased mucosa (nasal polyps, mucopurulent secretions,and/or inflamed mucosa) under endoscopy. (Lund-kennedy endoscopic score: Polyp≥1 or Oedema≥2 or Discharge≥2; 0-Absence of polyps;1-polyps in middle meatus only;2-polyps beyond middle meatus but not blocking the nose completely;3-polyps completely obstructing the nose. Oedema: 0-absent; 1-mild; 2-severe.Discharge: 0-no discharge; 1-clear, thin discharge; 2-thick, purulent discharge.)

    through study completion, an average of 2 year

Study Arms (1)

postoperational CRS

observe the symptoms and endoscopic appearance

Diagnostic Test: sinonasal outcome test-22

Interventions

Evaluate the nasal mucosal inflammation condition and overall quality-of-life of CRS patients

Also known as: Lund-Kennedy endoscopic score
postoperational CRS

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Chronic rhinosinusitis patients after endoscopic surgery

You may qualify if:

  • Diagnosis of chronic rhinosinusitis according to European position paper of rhinosinusitis and nasal polyps 2007.

You may not qualify if:

  • Immunodeficiency diseases, history of head and/or facial trauma, cancer or organ transplant recipients.
  • Pregnancy or lactation.
  • Acute respiratory tract infection within one month before the study.
  • Patients without pathological samples.
  • Antrochoanal polyp and cyst of the paranasal sinuses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the first affiliated hospital, Sun Yat-sen University

Guangzhou, Guangdong, 510080, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

The samples were abtained during endoscopic sinus surgery

MeSH Terms

Conditions

SinusitisNasal PolypsDisease

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsParanasal Sinus DiseasesNose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • Jianbo Shi, doctor

    Ent department, the first affiliated hospital, Sun Yat-sen University

    STUDY DIRECTOR

Central Study Contacts

Jianbo Shi, doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 27, 2017

First Posted

December 15, 2017

Study Start

January 1, 2016

Primary Completion

January 1, 2018

Study Completion

June 1, 2018

Last Updated

December 15, 2017

Record last verified: 2017-12

Locations